Diseño e implementación de un modelo de trazabilidad descentralizada en la cadena de suministro de medicamentos

Abstract

Existing vulnerabilities in the pharmaceutical supply chain and the need to strengthen control mechanisms to guarantee the authenticity and proper storage of pharmaceutical products are highlighted. The premise is that the circulation of counterfeit medicines and deficiencies in monitoring environmental conditions during transport and storage constitute significant risks to public health. These problems can compromise the quality of medicines, affect their therapeutic efficacy, and generate negative consequences for both patients and the institutions responsible for their distribution. Given this scenario, it is proposed that the incorporation of emerging technologies can contribute to improving the traceability and transparency of logistics processes. In particular, blockchain technology is presented as an alternative capable of securely and immutably recording information associated with each stage of the supply chain, from production to final delivery. It is argued that this approach reduces the possibility of data manipulation, detects irregularities more quickly, and strengthens trust among the various stakeholders. Furthermore, the integration of environmental monitoring mechanisms facilitates the control of medicine storage conditions. Taken together, the proposal demonstrates the potential of digital technologies to increase the safety, efficiency, and reliability of contemporary pharmaceutical systems